Navigation Links
Yongye Biotechnology International Announces Second Quarter Results
Date:8/18/2008

redecessor, Inner Mongolia Yongye Biotechnology Company, Ltd

On April 17, 2008, Yongye Biotechnology International Inc. signed a private financing agreement to raise $10.0 million gross proceeds. The transaction closed in May 2008.

In June, the Company signed construction contracts to begin construction of a new facility at its current location with processing capacity of 8,000 TPA. The value of these contracts is approximately RMB 25,000,000 (approximately $3.6 million). This additional facility will increase total production capacity to 10,000 TPA and is critical for the Company to be able to keep up with anticipated demand. As of July 2008, the new facility was forecast to be operational by the end of September 2008.

In June, Yongye engaged MSPC Certified Public Accountants and Advisors, P.C. as the Company's independent auditor.

Business Outlook

"As food production in China continues to increase, we believe demand will continue to increase for our plant and animal nutrients. We plan to sustain our business growth by expanding our distribution and sales network, and broadening our geographic market coverage. We also plan to provide more technical assistance to our customers and help them achieve the best possible consistent results by using our products," stated Mr. Wu.

Conference Call

The Company will host a conference call at 08:00 a.m. Eastern time on Monday, August 18, 2008 to discuss its second quarter 2008 results.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 1-888- 339-2688. International callers should dial +1-617-847-3007. The conference pass code is 899 273 89.

For those who are unable to participate in the conference call at the time of the call, a replay will be available for fourteen days after the call is held. To access the replay, please dial 1-888-286-8010. International callers should dia
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
2. Yongye Biotechnology International Retains CCG Investor Relations
3. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
4. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
5. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
6. New Book on the Business of Biotechnology
7. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
8. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Pennsylvania Governor Rendell Says State Number 1 in New Biotechnology Study
11. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)...  AsureQuality and Ubiquitome have agreed to collaborate ... food and primary production sectors. The collaboration will ... the Freedom4. AsureQuality provides quality assurance ... shelf for producers, processors and Competent Authorities around ... control and pest management and surveillance programmes. ...
(Date:7/29/2015)... -- Research and Markets ( ... "Global Biosimilars Market, 2015 - 2025" ... Biosimilars Market, 2015 - 2025, report provides an ... With the blockbuster biologics losing patent protection and ... being viewed as viable substitutes to the highly ...
(Date:7/29/2015)... -- AmnioChor Inc., an early stage biotech startup based on ... that the Musculoskeletal Transplant Foundation of Edison ... seed round of development of the proprietary AmnioCept™ product ... AmnioChor,s technology allows cryopreservation of the amniotic membrane ... within those tissues. Amnion is a well-established source of ...
(Date:7/29/2015)... , July 29, 2015  Pfenex Inc. (NYSE MKT: ... results will be released on Thursday, August 13, 2015, ... Time, Pfenex management will host a conference call to ... A press release outlining the financial results and business ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) ...
Breaking Biology Technology:AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2
... Sept. 19 NPS,Pharmaceuticals, Inc. (Nasdaq: NPSP ... Administration,s Office of Orphan Products Development has granted,orphan ... for,injection) for the treatment of hypoparathyroidism, a rare ... FDA-approved therapy. Hypoparathyroidism afflicts approximately 65,000 people ...
... NeurogesX, Inc.,(Nasdaq: NGSX ), a biopharmaceutical company ... it is scheduled to present,at the 2007 UBS Global ... President and Chief Executive Officer, and Jeffery,Tobias, Chief Medical ... September 25, 2007 Time: 9:00 a.m. ...
... Sept. 19 The Pittsburgh Life Sciences,Greenhouse ... life,sciences industry on a fast track for ... in Coventina Healthcare Enterprises, Inc., a medical,device ... Frequency),and multi-modal treatment systems for research, rehabilitation, ...
Cached Biology Technology:PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism 2PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism 3NeurogesX to Present at UBS 2007 Global Life Sciences Conference 2NeurogesX to Present at UBS 2007 Global Life Sciences Conference 3The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh 2The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh 3
(Date:7/7/2015)... MOUNTAIN VIEW, Calif. , July 7, 2015 ... mobile biometrics market, Frost & Sullivan recognizes Credence ... & Sullivan Entrepreneurial Company of the Year ... product suite to aid in its mission of ... and under-recognized populations globally. As Credence ID was ...
(Date:7/2/2015)... GOTHENBURG, Sweden , July 2, 2015 ... fingerprint sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor ... is one of FPC,s distributors in Asia ... Q4 2015. The sensors will be used by smartphone manufacturers ... 268 MSEK is included in the communicated revenue guidance of ...
(Date:6/26/2015)... ATL Technology, LLC, a top provider of electromechanical contract manufacturing ... headquartered in Springville, Utah , has announced ... corporation with locations in Santa Clara, CA ... ). This acquisition will incorporate MedConx,s manufacturing facility ... existing facility in Costa Rica , resulting ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... Md., April 7, 2011 The American Society for ... associate professor at University of Massachusetts Medical School, the ... present his award lecture, titled "Three-dimensional Folding of Genomes," ... Biology conference at the Walter E. Washington Convention Center ...
... to even one of the thousands of DNA codes that ... in severe diseases such as cancer, cystic fibrosis, muscular dystrophy ... of a virus or bacteria can give rise to drug ... standard drug therapies. For these reasons, scientists have long sought ...
... gene introduced into soybean plants has increased the amount of ... helping meet nutritional needs of a hungry world. Eve ... Li, an adjunct assistant professor and an associate scientist working ... Arabidopsis plants into soybean plants and increased the amount of ...
Cached Biology News:UMass med school professor wins coveted emerging-investigator award 2UMMS researchers develop new technology to screen and analyze genetic mutations 2UMMS researchers develop new technology to screen and analyze genetic mutations 3Starch-controlling gene fuels more protein in soybean plants 2
... Explorer processes up to 48 lanes, 24 ... input can be from either slab gel ... primer chemistries. The detection parameters in Explorer ... analyst consistency. We have built Explorer ...
Molecular Biological Resources offers bulk quantities of existing protein products. Please see the Chimerx divisions website for existing products and contact lloconne@molbiores.com for pricing....
... Quality ISO 9001:2000 Certified USDA ... Precedures Validated, SOP's Training AALAS ... for All Procedures GLP Documentation Upon Request ... stop shopping point for all your custom ...
... XL provides balance data collection and automation that ... integration with Microsoft Excel , Pre-configured library ... , New balances can be added and configured ... from multiple balances into one spreadsheet ...
Biology Products: